世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

神経調節デバイスの市場規模、シェア、動向分析レポート:製品タイプ別(脊髄刺激装置、脳深部刺激装置)、技術別、用途別、生体材料別、最終用途別、地域別、およびセグメント予測、2022年~2030年


Neuromodulation Devices Market Size, Share & Trends Analysis Report By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators), By Technology, By Application, By Biomaterial, By End-use, By Region, And Segment Forecasts, 2022 - 2030

神経調節デバイス市場の成長とトレンド グランドビューリサーチ社の最新レポートによると、神経調節デバイスの世界市場規模は2030年までに83億米ドルに達すると予測されています。2022年から2030年にかけては... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年7月20日 US$5,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
100 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

神経調節デバイス市場の成長とトレンド

グランドビューリサーチ社の最新レポートによると、神経調節デバイスの世界市場規模は2030年までに83億米ドルに達すると予測されています。2022年から2030年にかけては、CAGR9.5%で拡大すると予測されています。神経調節は、神経疾患の治療において、低侵襲または非侵襲の治療オプションを提供します。また、発展途上国における医療予算配分の増加が、市場成長に寄与することが期待されます。例えば、米国では、2020年の国民医療費は4.1兆米ドル、1人当たり12,530米ドルまで増加しました。

COVID-19のパンデミックは、世界中のさまざまな産業や取引に大混乱を引き起こしていました。高齢者は、さまざまな併存疾患や免疫抑制の可能性により、慢性的な痛みにさらされる可能性が高いため、神経調節の需要は高齢者層でより高くなっています。さらに、COVID-19ウイルスに感染した人々の間で需要が増加すると予想されます。この病気は、免疫系を効果的に抑制するのです。

医療インフラを改善するための政府や市場関係者による投資の大幅な増加は、神経症状を治療するための新規技術の導入を促進しています。2021年の連邦予算において、PM Atmanirbhar Swasth Bharat Yojanaは、インド政府から6年間で総額81億米ドルの資金を受け取りました。この資金は、既存の国立医療機関を強化し、一次、二次、三次医療システムの能力を開発し、新興疾患の検出に対応するために配分された。

この市場で事業を展開する主要企業は、自社製品についてFDAの認可を受けています。組織は、グローバルリーチを拡大しながら競争力を強化するために、提携、買収、パートナーシップ、研究開発投資、新製品の上市、承認などの戦略を取り入れています。例えば、2021年9月、アボットは、医療機器製造会社であるWalk Vascular, LLCを買収しました。Walk Vascular, LLCは、血栓の除去を目的とした低侵襲血栓除去システムで知られています。

神経調節デバイス市場レポートハイライト

- 製品タイプ別では、脊髄刺激装置が2021年に40.0%超の収益シェアを獲得し、市場を支配しました。脳深部刺激装置は、本態性振戦、パーキンソン病、ジストニア、てんかんの治療への利用が増加していることから、予測期間中に10.8%の最速成長率を記録すると予想される

- 技術別では、さまざまな神経疾患の治療に低侵襲治療の使用が増加していることから、2021年には内部セグメントが55.0%超のシェアを占めています。外部セグメントは、予測期間中に最も速いCAGR 10.8%で拡大すると予想されます。

- 用途別では、パーキンソン病分野が2021年に25.0%超の最大の収益シェアを占めた。慢性疼痛セグメントは予測期間中に11.3%の最速成長を示すと予想される

- バイオマテリアルに基づくと、金属バイオマテリアルセグメントが市場を支配し、研究開発活動の成長により2021年に45.0%超のシェアを占めた

- 2021年には、さまざまな種類の神経疾患の有病率が上昇し、神経調節デバイスや治療法のニーズが繰り返されていることから、北米が45.0%超の収益シェアで市場を支配した。アジア太平洋地域は、予測期間中に10.6%という最速の速度で拡大すると予想されています。この成長の背景には、人口の高齢化と政府の取り組みの増加があります。例えば、NITI Aayogは保健家族福祉省とともに、2016年に神経障害に苦しむ患者のための無償診断プログラムを開始した



ページTOPに戻る


目次

Table of Contents

Chapter 1 Report Scope and Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 GVR’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product Type
3.2.2 Technology
3.2.3 Application
3.2.4 Biomaterial
3.2.5 End Use
3.2.6 Region
3.3 Competitive Insights
3.4 Neuromodulation Devices Market Outlook, 2021
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market Outlook
4.2 Neuromodulation Devices Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Harnessing digital health solutions
4.2.1.2 A rise in the number of patients with neurological disorders
4.2.2 Market Restraint Analysis
4.2.2.1 Less number of skilled labor
4.3 Neuromodulation Devices Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat of new entrants
4.3.1.2 Bargaining power of suppliers
4.3.1.3 Bargaining power of buyers
4.3.1.4 Competitive rivalry
4.3.1.5 Threat of substitutes
4.3.2 Pestel Analysis
4.3.2.1 Political & Legal
4.3.2.2 Economic & Social
4.3.2.3 Technological
4.3.2.4 Environmental
4.4 Penetration & Growth Prospect Mapping
4.5 Technology Trend Analysis
4.6 Regulatory Framework
4.7 Impact of COVID-19 on Neuromodulation Devices Market
Chapter 5 Neuromodulation Devices Market: Product Type Analysis
5.1 Neuromodulation Devices Product Type Market Share Analysis, 2021 & 2030
5.2 Neuromodulation Devices Product Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
5.3.1 Spinal Cord Stimulators
5.3.1.1 Spinal cord stimulators market, 2017 - 2030 (USD Million)
5.3.2 Deep Brain Stimulators
5.3.2.1 Deep brain stimulators market, 2017 - 2030 (USD Million)
5.3.3 Sacral Nerve Stimulators
5.3.3.1 Sacral nerve stimulators market, 2017 - 2030 (USD Million)
5.3.4 Vagus Nerve Stimulators
5.3.4.1 Vagus nerve stimulators market, 2017 - 2030 (USD Million)
5.3.5 Transcranial Magnetic Stimulators
5.3.5.1 Transcranial magnetic stimulators market, 2017 - 2030 (USD Million)
5.3.6 Others
5.3.6.1 Others market, 2017 - 2030 (USD Million)
Chapter 6 Neuromodulation Devices Market: Technology Analysis
6.1 Neuromodulation Devices Technology Market Share Analysis, 2021 & 2030
6.2 Neuromodulation Devices technology Market: Segment Dashboard:
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Technology Segment
6.3.1 Internal
6.3.1.1 Internal market, 2017 - 2030 (USD Million)
6.3.2 External
6.3.2.1 External market, 2017 - 2030 (USD Million)
Chapter 7 Neuromodulation Devices Market: Application Analysis
7.1 Neuromodulation Devices Application Market Share Analysis, 2021 & 2030
7.2 Neuromodulation Devices Application Market: Segment Dashboard
7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment
7.3.1 Parkinson’s Disease
7.3.1.1 Parkinson’s disease market, 2017- 2030 (USD Million)
7.3.2 Chronic Pain
7.3.2.1 Chronic pain market, 2017 - 2030 (USD Million)
7.3.3 Migraine
7.3.3.1 Migraine market, 2017- 2030 (USD Million)
7.3.4 Epilepsy
7.3.4.1 Epilepsy market, 2017- 2030 (USD Million)
7.3.5 Tremor
7.3.5.1 Tremor market, 2017- 2030 (USD Million)
7.3.6 Depression
7.3.6.1 Depression market, 2017- 2030 (USD Million)
7.3.7 Urinary & Fecal Incontinence
7.3.7.1 Urinary & fecal incontinence, 2017- 2030 (USD Million)
7.3.8 Others
7.3.8.1 Others market, 2017- 2030 (USD Million)
Chapter 8 Neuromodulation Devices Market: Biomaterial Analysis
8.1 Neuromodulation Devices Biomaterial Market Share Analysis, 2021 & 2030
8.2 Neuromodulation Devices Biomaterial Market: Segment Dashboard
8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Biomaterial
8.3.1 Polymeric Biomaterial
8.3.1.1 Polymeric biomaterial market, 2017- 2030 (USD Million)
8.3.2 Metallic Biomaterial
8.3.2.1 Metallic biomaterial market, 2017 - 2030 (USD Million)
8.3.3 Ceramic Biomaterial
8.3.3.1 Ceramic biomaterial market, 2017- 2030 (USD Million)
Chapter 9 Neuromodulation Devices Market: End-Use Analysis
9.1 Neuromodulation Devices Type Market Share Analysis, 2021 & 2030
9.2 Neuromodulation Devices Type Market: Segment Dashboard
9.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
9.3.1 Clinics & Physiotherapy Centers
9.3.1.1 Clinics & physiotherapy centers market, 2017- 2030 (USD Million)
9.3.2 Hospitals & Ambulatory Centers
9.3.2.1 Hospitals & ambulatory centers market, 2017- 2030 (USD Million)
9.3.3 Others
9.3.3.1 Others market, 2017- 2030 (USD Million)
Chapter 10 Neuromodulation Devices Market: Regional Analysis
10.1 Neuromodulation Devices Regional Market Share Analysis, 2021 & 2030
10.2 Regional Market Snapshot
10.3 North America
10.3.1 North America Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.3.2 U.S.
10.3.2.1 U.S. neuromodulation devices market, 2017 - 2030 (USD Million)
10.3.3 Canada
10.3.3.1 Canada neuromodulation devices market, 2017 - 2030 (USD Million)
10.4 Europe
10.4.1 Europe Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.4.2 U.K.
10.4.2.1 U.K. neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.3 Germany
10.4.3.1 Germany neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.4 France
10.4.4.1 France neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.5 Italy
10.4.5.1 Italy neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.6 Spain
10.4.6.1 Spain neuromodulation devices market, 2017 - 2030 (USD Million)
10.5 Asia Pacific
10.5.1 Asia Pacific Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.5.2 Japan
10.5.2.1 Japan neuromodulation devices market, 2017 - 2030 (USD Million)
10.5.3 China
10.5.3.1 China neuromodulation devices market, 2017 - 2030 (USD Million)
10.5.4 India
10.5.4.1 India neuromodulation devices market, 2017 - 2030 (USD Million)
10.6 Latin America
10.6.1 Latin America Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.6.2 Brazil
10.6.2.1 Brazil neuromodulation devices market, 2017 - 2030 (USD Million)
10.6.3 Mexico
10.6.3.1 Mexico neuromodulation devices market, 2017 - 2030 (USD Million)
10.7 Middle East and Africa (MEA)
10.7.1 MEA Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.7.2 South Africa
10.7.2.1 South Africa neuromodulation devices market, 2017 - 2030 (USD Million)
Chapter 11 Competitive Analysis
11.1 Recent Developments & Impact Analysis, By Key Market Participants
11.2 Company Profiles
11.2.1 MEDTRONIC
11.2.1.1 Company overview
11.2.1.2 Financial performance
11.2.1.3 Product benchmarking
11.2.1.4 Strategic initiatives
11.2.2 LIVANOVA PLC
11.2.2.1 Company overview
11.2.2.2 Financial performance
11.2.2.3 Product benchmarking
11.2.2.4 Strategic initiatives
11.2.3 NEVRO CORPORATION
11.2.3.1 Company overview
11.2.3.2 Financial performance
11.2.3.3 Product benchmarking
11.2.3.4 Strategic initiatives
11.2.4 BIOVENTUS INC.
11.2.4.1 Company overview
11.2.4.2 Financial performance
11.2.4.3 Product benchmarking
11.2.4.4 Strategic initiatives
11.2.5 NEUROPACE INC.
11.2.5.1 Company overview
11.2.5.2 Financial performance
11.2.5.3 Product benchmarking
11.2.5.4 Strategic initiatives
11.2.6 BOSTON SCIENTIFIC CORPORATION
11.2.6.1 Company overview
11.2.6.2 Financial performance
11.2.6.3 Product benchmarking
11.2.6.4 Strategic initiatives
11.2.7 ABBOTT LABORATORIES
11.2.7.1 Company overview
11.2.7.2 Financial performance
11.2.7.3 Product benchmarking
11.2.7.4 Strategic initiative
11.2.8 NEURONETICS
11.2.8.1 Company overview
11.2.8.2 Financial performance
11.2.8.3 Product benchmarking
11.2.8.4 Strategic initiatives
11.2.9 INSPIRE MEDICAL SYSTEM INC.
11.2.9.1 Company overview
11.2.9.2 Fperformance
11.2.9.3 Product benchmarking
11.2.9.4 Strategic initiatives
11.2.10 ELECTROCORE INC.
11.2.10.1 Company overview
11.2.10.2 Financial performance
11.2.10.3 Product benchmarking
11.2.10.4 Strategic initiatives

 

ページTOPに戻る


 

Summary

Neuromodulation Devices Market Growth & Trends

The global neuromodulation devices market size is expected to reach USD 8.3 billion by 2030, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2022 to 2030. Neuromodulation offers minimally invasive or non-invasive treatment options for the treatment of neurological diseases. In addition, the growth in the healthcare budgetary allocation in developing countries is expected to contribute to the market growth. For instance, in the U.S., national healthcare spending increased to USD 4.1 trillion in 2020, or USD 12,530 per person.

The COVID-19 pandemic had caused havoc in a variety of industries and trades around the world. The demand for neuromodulation is higher among the older population as they are more likely to be exposed to chronic pain due to various comorbidities and probable immune suppression. Furthermore, the demand is expected to increase among persons infected with the COVID-19 virus. The illness effectively suppresses the immune system.

The significant increase in investments by the government and market players to improve the healthcare infrastructure is promoting the implementation of novel technologies to treat neurological conditions. In the Union Budget of 2021, the PM Atmanirbhar Swasth Bharat Yojana received funding from the government of India totaling USD 8.10 billion over six years. The fund was allocated to strengthen existing national medical institutions to develop capacities of primary, secondary, and tertiary healthcare systems and cater to the detection of emerging diseases.

Major players operating in the market are receiving FDA approval for their products. The organizations are incorporating strategies such as alliances, acquisitions, partnerships, R&D investments, new product launches, and approvals to strengthen their competitive power while expanding their global reach. For instance, in September 2021, Abbott acquired Walk Vascular, LLC, which is a medical device manufacturing company. Walk Vascular, LLC is known for the minimally invasive thrombectomy system that is designed for the removal of blood clots.

Neuromodulation Devices Market Report Highlights

• Based on product type, the spinal cord stimulators segment dominated the market with a revenue share of over 40.0% in 2021. Deep brain stimulators are expected to register the fastest growth rate of 10.8% over the forecast period owing to an increase in the usage of deep brain stimulators for treating essential tremors, Parkinson’s disease, dystonia, and epilepsy

• Based on technology, the internal segment dominated the market with a share of over 55.0% in 2021 owing to the increased use of minimally invasive treatments for treating various neurological disorders. The external segment is expected to expand at the fastest CAGR of 10.8% during the forecast period

• Based on application, the Parkinson’s disease segment held the largest revenue share of over 25.0% in 2021. The chronic pain segment is expected to exhibit the fastest growth of 11.3% during the forecast period

• Based on biomaterial, the metallic biomaterials segment dominated the market and held over 45.0% share in 2021 owing to the growth in R&D activities

• In 2021, North America dominated the market with a revenue share of over 45.0% owing to the rising prevalence of various types of neurological illnesses and the recurring need for neuromodulation devices and therapies. Asia Pacific is expected to expand at the fastest rate of 10.6% during the forecast period. The growth can be attributed to an aging population and rising government initiatives. For instance, NITI Aayog along with the Ministry of Health and Family Welfare launched a no-cost diagnostic program for patients suffering from neurological disorders in 2016



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Report Scope and Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 GVR’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product Type
3.2.2 Technology
3.2.3 Application
3.2.4 Biomaterial
3.2.5 End Use
3.2.6 Region
3.3 Competitive Insights
3.4 Neuromodulation Devices Market Outlook, 2021
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market Outlook
4.2 Neuromodulation Devices Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Harnessing digital health solutions
4.2.1.2 A rise in the number of patients with neurological disorders
4.2.2 Market Restraint Analysis
4.2.2.1 Less number of skilled labor
4.3 Neuromodulation Devices Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat of new entrants
4.3.1.2 Bargaining power of suppliers
4.3.1.3 Bargaining power of buyers
4.3.1.4 Competitive rivalry
4.3.1.5 Threat of substitutes
4.3.2 Pestel Analysis
4.3.2.1 Political & Legal
4.3.2.2 Economic & Social
4.3.2.3 Technological
4.3.2.4 Environmental
4.4 Penetration & Growth Prospect Mapping
4.5 Technology Trend Analysis
4.6 Regulatory Framework
4.7 Impact of COVID-19 on Neuromodulation Devices Market
Chapter 5 Neuromodulation Devices Market: Product Type Analysis
5.1 Neuromodulation Devices Product Type Market Share Analysis, 2021 & 2030
5.2 Neuromodulation Devices Product Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
5.3.1 Spinal Cord Stimulators
5.3.1.1 Spinal cord stimulators market, 2017 - 2030 (USD Million)
5.3.2 Deep Brain Stimulators
5.3.2.1 Deep brain stimulators market, 2017 - 2030 (USD Million)
5.3.3 Sacral Nerve Stimulators
5.3.3.1 Sacral nerve stimulators market, 2017 - 2030 (USD Million)
5.3.4 Vagus Nerve Stimulators
5.3.4.1 Vagus nerve stimulators market, 2017 - 2030 (USD Million)
5.3.5 Transcranial Magnetic Stimulators
5.3.5.1 Transcranial magnetic stimulators market, 2017 - 2030 (USD Million)
5.3.6 Others
5.3.6.1 Others market, 2017 - 2030 (USD Million)
Chapter 6 Neuromodulation Devices Market: Technology Analysis
6.1 Neuromodulation Devices Technology Market Share Analysis, 2021 & 2030
6.2 Neuromodulation Devices technology Market: Segment Dashboard:
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Technology Segment
6.3.1 Internal
6.3.1.1 Internal market, 2017 - 2030 (USD Million)
6.3.2 External
6.3.2.1 External market, 2017 - 2030 (USD Million)
Chapter 7 Neuromodulation Devices Market: Application Analysis
7.1 Neuromodulation Devices Application Market Share Analysis, 2021 & 2030
7.2 Neuromodulation Devices Application Market: Segment Dashboard
7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment
7.3.1 Parkinson’s Disease
7.3.1.1 Parkinson’s disease market, 2017- 2030 (USD Million)
7.3.2 Chronic Pain
7.3.2.1 Chronic pain market, 2017 - 2030 (USD Million)
7.3.3 Migraine
7.3.3.1 Migraine market, 2017- 2030 (USD Million)
7.3.4 Epilepsy
7.3.4.1 Epilepsy market, 2017- 2030 (USD Million)
7.3.5 Tremor
7.3.5.1 Tremor market, 2017- 2030 (USD Million)
7.3.6 Depression
7.3.6.1 Depression market, 2017- 2030 (USD Million)
7.3.7 Urinary & Fecal Incontinence
7.3.7.1 Urinary & fecal incontinence, 2017- 2030 (USD Million)
7.3.8 Others
7.3.8.1 Others market, 2017- 2030 (USD Million)
Chapter 8 Neuromodulation Devices Market: Biomaterial Analysis
8.1 Neuromodulation Devices Biomaterial Market Share Analysis, 2021 & 2030
8.2 Neuromodulation Devices Biomaterial Market: Segment Dashboard
8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Biomaterial
8.3.1 Polymeric Biomaterial
8.3.1.1 Polymeric biomaterial market, 2017- 2030 (USD Million)
8.3.2 Metallic Biomaterial
8.3.2.1 Metallic biomaterial market, 2017 - 2030 (USD Million)
8.3.3 Ceramic Biomaterial
8.3.3.1 Ceramic biomaterial market, 2017- 2030 (USD Million)
Chapter 9 Neuromodulation Devices Market: End-Use Analysis
9.1 Neuromodulation Devices Type Market Share Analysis, 2021 & 2030
9.2 Neuromodulation Devices Type Market: Segment Dashboard
9.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
9.3.1 Clinics & Physiotherapy Centers
9.3.1.1 Clinics & physiotherapy centers market, 2017- 2030 (USD Million)
9.3.2 Hospitals & Ambulatory Centers
9.3.2.1 Hospitals & ambulatory centers market, 2017- 2030 (USD Million)
9.3.3 Others
9.3.3.1 Others market, 2017- 2030 (USD Million)
Chapter 10 Neuromodulation Devices Market: Regional Analysis
10.1 Neuromodulation Devices Regional Market Share Analysis, 2021 & 2030
10.2 Regional Market Snapshot
10.3 North America
10.3.1 North America Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.3.2 U.S.
10.3.2.1 U.S. neuromodulation devices market, 2017 - 2030 (USD Million)
10.3.3 Canada
10.3.3.1 Canada neuromodulation devices market, 2017 - 2030 (USD Million)
10.4 Europe
10.4.1 Europe Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.4.2 U.K.
10.4.2.1 U.K. neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.3 Germany
10.4.3.1 Germany neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.4 France
10.4.4.1 France neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.5 Italy
10.4.5.1 Italy neuromodulation devices market, 2017 - 2030 (USD Million)
10.4.6 Spain
10.4.6.1 Spain neuromodulation devices market, 2017 - 2030 (USD Million)
10.5 Asia Pacific
10.5.1 Asia Pacific Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.5.2 Japan
10.5.2.1 Japan neuromodulation devices market, 2017 - 2030 (USD Million)
10.5.3 China
10.5.3.1 China neuromodulation devices market, 2017 - 2030 (USD Million)
10.5.4 India
10.5.4.1 India neuromodulation devices market, 2017 - 2030 (USD Million)
10.6 Latin America
10.6.1 Latin America Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.6.2 Brazil
10.6.2.1 Brazil neuromodulation devices market, 2017 - 2030 (USD Million)
10.6.3 Mexico
10.6.3.1 Mexico neuromodulation devices market, 2017 - 2030 (USD Million)
10.7 Middle East and Africa (MEA)
10.7.1 MEA Neuromodulation Devices Market, 2017 - 2030 (USD Million)
10.7.2 South Africa
10.7.2.1 South Africa neuromodulation devices market, 2017 - 2030 (USD Million)
Chapter 11 Competitive Analysis
11.1 Recent Developments & Impact Analysis, By Key Market Participants
11.2 Company Profiles
11.2.1 MEDTRONIC
11.2.1.1 Company overview
11.2.1.2 Financial performance
11.2.1.3 Product benchmarking
11.2.1.4 Strategic initiatives
11.2.2 LIVANOVA PLC
11.2.2.1 Company overview
11.2.2.2 Financial performance
11.2.2.3 Product benchmarking
11.2.2.4 Strategic initiatives
11.2.3 NEVRO CORPORATION
11.2.3.1 Company overview
11.2.3.2 Financial performance
11.2.3.3 Product benchmarking
11.2.3.4 Strategic initiatives
11.2.4 BIOVENTUS INC.
11.2.4.1 Company overview
11.2.4.2 Financial performance
11.2.4.3 Product benchmarking
11.2.4.4 Strategic initiatives
11.2.5 NEUROPACE INC.
11.2.5.1 Company overview
11.2.5.2 Financial performance
11.2.5.3 Product benchmarking
11.2.5.4 Strategic initiatives
11.2.6 BOSTON SCIENTIFIC CORPORATION
11.2.6.1 Company overview
11.2.6.2 Financial performance
11.2.6.3 Product benchmarking
11.2.6.4 Strategic initiatives
11.2.7 ABBOTT LABORATORIES
11.2.7.1 Company overview
11.2.7.2 Financial performance
11.2.7.3 Product benchmarking
11.2.7.4 Strategic initiative
11.2.8 NEURONETICS
11.2.8.1 Company overview
11.2.8.2 Financial performance
11.2.8.3 Product benchmarking
11.2.8.4 Strategic initiatives
11.2.9 INSPIRE MEDICAL SYSTEM INC.
11.2.9.1 Company overview
11.2.9.2 Fperformance
11.2.9.3 Product benchmarking
11.2.9.4 Strategic initiatives
11.2.10 ELECTROCORE INC.
11.2.10.1 Company overview
11.2.10.2 Financial performance
11.2.10.3 Product benchmarking
11.2.10.4 Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Grand View Research社の高分子材料分野での最新刊レポート

本レポートと同じKEY WORD(biomaterial)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る